BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21402997)

  • 1. Multifaceted chemotherapy for trilateral retinoblastoma.
    Dimaras H; Héon E; Doyle J; Strahlendorf C; Paton KE; Halliday W; Babyn P; Gallie BL; Chan HS
    Arch Ophthalmol; 2011 Mar; 129(3):362-5. PubMed ID: 21402997
    [No Abstract]   [Full Text] [Related]  

  • 2. Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
    Dai S; Dimaras H; Héon E; Budning A; Doyle J; Halliday W; Drake J; Gallie BL; Chan HS
    Ophthalmic Genet; 2008 Sep; 29(3):120-5. PubMed ID: 18766991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
    Dunkel IJ; Jubran RF; Gururangan S; Chantada GL; Finlay JL; Goldman S; Khakoo Y; O'Brien JM; Orjuela M; Rodriguez-Galindo C; Souweidane MM; Abramson DH
    Pediatr Blood Cancer; 2010 Mar; 54(3):384-7. PubMed ID: 19908299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of neonatal trilateral retinoblastoma.
    Bindlish R; LaRoche GR
    J AAPOS; 1999 Dec; 3(6):376-8. PubMed ID: 10613584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of systemic chemotherapy as treatment of retinoblastoma.
    Benz MS; Scott IU; Murray TG; Kramer D; Toledano S
    Arch Ophthalmol; 2000 Apr; 118(4):577-8. PubMed ID: 10766148
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized, controlled trial in groups C and D retinoblastoma.
    Meel R; Bakhshi S; Pushker N; Vishnubhatla S
    Ophthalmology; 2015 Feb; 122(2):433-5. PubMed ID: 25439612
    [No Abstract]   [Full Text] [Related]  

  • 7. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
    Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoreduction for nonvisualized retinoblastoma hidden behind dense cataract.
    Nallasamy S; Ramasubramanian A; Shields CL; Tipperman R; Shields JA
    Can J Ophthalmol; 2010 Oct; 45(5):539-40. PubMed ID: 20648072
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the best treatment for retinoblastoma?
    Harbour JW
    Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).
    Shields CL; Meadows AT; Shields JA; Carvalho C; Smith AF
    Arch Ophthalmol; 2001 Sep; 119(9):1269-72. PubMed ID: 11545631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
    Mathew AA; Sachdev N; Staffieri SE; McKenzie JD; Elder JE
    J AAPOS; 2015 Feb; 19(1):72-4. PubMed ID: 25727592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for retinoblastoma.
    Chan HS; Gallie BL; Munier FL; Beck Popovic M
    Ophthalmol Clin North Am; 2005 Mar; 18(1):55-63, viii. PubMed ID: 15763191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
    Kim JW; Yau JW; Moshfeghi D; Fishman M
    J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-4. PubMed ID: 21214147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of early detected trilateral retinoblastoma using standard infant brain tumor therapy.
    Wright KD; Qaddoumi I; Patay Z; Gajjar A; Wilson MW; Rodriguez-Galindo C
    Pediatr Blood Cancer; 2010 Sep; 55(3):570-2. PubMed ID: 20658634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual intraretinal retinoblastoma after chemoreduction failure.
    Hwang CK; Aaberg TM; Chevez-Barrios P; Verner-Cole E; Gombos DS; Paysse E; Chintagumpala M; Gao W; Grossniklaus HE
    Arch Ophthalmol; 2012 Feb; 130(2):246-8. PubMed ID: 22332223
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffuse infiltrating retinoblastoma with central nervous system metastasis.
    Khetan V; Al-Kharusi N; Ganesh A; Al-Futaisi A; Biswas J; Kumar K; Raja T
    Arch Ophthalmol; 2011 Mar; 129(3):375-7. PubMed ID: 21403001
    [No Abstract]   [Full Text] [Related]  

  • 18. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diffuse anterior retinoblastoma].
    Herwig MC; Hubbard GB; Wells JR; Grossniklaus HE
    Ophthalmologe; 2011 Oct; 108(10):969-72. PubMed ID: 21528372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
    Dimaras H; Khetan V; Halliday W; Héon E; Chan HS; Gallie BL
    Arch Ophthalmol; 2009 Aug; 127(8):1066-8. PubMed ID: 19667353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.